ngd 94-1 has been researched along with Schizophrenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bristow, LJ; Hutson, PH; Rowley, M | 1 |
| Cochrane, EV; Conley, RR; Gallager, DW; Lahti, RA; Primus, RJ; Roberts, RC; Tamminga, CA | 1 |
1 review(s) available for ngd 94-1 and Schizophrenia
| Article | Year |
|---|---|
Current and novel approaches to the drug treatment of schizophrenia.
Topics: Animals; Antipsychotic Agents; Cholinergic Agonists; Disease Models, Animal; Dopamine Antagonists; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Humans; Mice; Mice, Transgenic; Nitric Oxide Synthase; Receptor, Serotonin, 5-HT2A; Receptors, AMPA; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotensin; Receptors, Serotonin; Schizophrenia; Serotonin Antagonists | 2001 |
1 other study(ies) available for ngd 94-1 and Schizophrenia
| Article | Year |
|---|---|
Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study.
Topics: Adult; Antipsychotic Agents; Autopsy; Autoradiography; Dopamine Antagonists; Entorhinal Cortex; Female; Hippocampus; Humans; Imidazoles; Male; Organ Specificity; Pyrimidines; Receptors, Dopamine D2; Receptors, Dopamine D4; Reference Values; Schizophrenia; Tritium | 1998 |